Integra Lifesciences Holdings Corp
Integra Lifesciences Holdings's GHG Emissions Data Preview
In 2024, Integra Lifesciences Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Integra Lifesciences Holdings has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind Integra Lifesciences Holdings’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Integra Lifesciences Holdings’s data sources below and access millions more through our Disclosure Search.
Insights into Integra Lifesciences Holdings's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Integra Lifesciences Holdings amounted to 26,499 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Integra Lifesciences Holdings increased by 12.24%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Integra Lifesciences Holdings's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Integra Lifesciences Holdings's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Integra Lifesciences Holdings were 14,555 metric tons of CO₂ equivalent (tCO₂e). a
Has Integra Lifesciences Holdings reduced its Scope 1 emissions over time?
Since 2022, Integra Lifesciences Holdings's Scope 1 emissions have increased by 10.14%, reflecting a rising long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2023), Integra Lifesciences Holdings's Scope 1 emissions increased by 75.85%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Integra Lifesciences Holdings's Scope 2 emissions?
In 2024, Integra Lifesciences Holdings reported Scope 2 greenhouse gas (GHG) emissions of 11,944 tCO₂e without specifying the calculation method. a
Has Integra Lifesciences Holdings reduced its Scope 2 emissions over time?
Since 2022, Integra Lifesciences Holdings's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 26.32%, reflecting a declining long-term trend in Scope 2 emissions over time. a
Compared to the previous year (2023), Integra Lifesciences Holdings's Scope 2 emissions (Unspecified Calculation Method) fell by 22.1% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a
What methodology does Integra Lifesciences Holdings use for Scope 2 reporting?
In 2024, Integra Lifesciences Holdings reported its Scope 2 emissions using an unspecified methodology. a
Integra Lifesciences Holdings's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Integra Lifesciences Holdings's Value Chain Emissions
In 2024, Integra Lifesciences Holdings reported 96,161 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of Integra Lifesciences Holdings includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Integra Lifesciences Holdings's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Integra Lifesciences Holdings's Scope 3 emissions?
In 2024, Integra Lifesciences Holdings reported total Scope 3 emissions of 96,161 metric tons of CO₂ equivalent (tCO₂e). a
Has Integra Lifesciences Holdings reduced its Scope 3 emissions over time?
Since 2022, Integra Lifesciences Holdings's Scope 3 emissions have decreased by 39.51%, reflecting a declining long-term trend in Scope 3 emissions over time. a
Compared to the previous year (2023), Integra Lifesciences Holdings's Scope 3 emissions decreased by 38.64%, highlighting the company's efforts to lower indirect emissions from its value chain. a
Insights into Integra Lifesciences Holdings’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Integra Lifesciences Holdings reported Scope 1 greenhouse gas (GHG) emissions of 14,555 tCO₂e and total revenues of USD 1,611 millions. This translates into an emissions intensity of 9.04 tCO₂e per millions USD. a
Integra Lifesciences Holdings's Scope 1 Emissions Intensity Compared to Peers
How does Integra Lifesciences Holdings's GHG emissions intensity compare to its peers?
In 2024, Integra Lifesciences Holdings reported a Scope 1 emissions intensity of 9.04 tCO₂e per millions USD. Compared to the peer group median of 2.78 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Integra Lifesciences Holdings rank on GHG emissions intensity within its industry?
In 2024, Integra Lifesciences Holdings ranked 19 out of 20 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Integra Lifesciences Holdings among the least efficient performers, with one of the highest emissions intensities in its sector. a
Insights into Integra Lifesciences Holdings's Total Carbon Footprint
In 2024, Integra Lifesciences Holdings reported a total carbon footprint of 122,660 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 31.97% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output. a
The largest contributor to Integra Lifesciences Holdings's total carbon footprint was Scope 3 emissions, accounting for 78.4% of the company's total carbon footprint, followed by Scope 1 emissions at 11.87%. a